germline mutation hereditary human neoplastic syndromes paragangliomas pheochromocytomas succinate dehydrogenase subunit B

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2022
Historique:
received: 20 07 2022
accepted: 08 11 2022
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 24 1 2023
Statut: epublish

Résumé

Pheochromocytomas (PCCs) and paragangliomas (PGLs) (known as PPGL in combination) are rare neuroendocrine tumors of the adrenal medulla and extra-adrenal ganglia. About 40% of the patients with PPGL have a hereditary predisposition. Here we present a case-series of 19 unrelated Colombian patients with a clinical diagnosis of PPGL tumors that underwent germline genetic testing as part of the Hereditary Cancer Program developed at the Instituto Nacional de Cancerología, Colombia (INC-C), the largest reference cancer center in the country. Ten of 19 patients (52.63%) were identified as carriers of a pathogenic/likely pathogenic (P/LP) germline variant in a known susceptibility gene. The majority of the P/LP variants were in the

Identifiants

pubmed: 36685941
doi: 10.3389/fgene.2022.999329
pii: 999329
pmc: PMC9845289
doi:

Types de publication

Journal Article

Langues

eng

Pagination

999329

Informations de copyright

Copyright © 2023 Manotas, Rivera, Gómez, Abisambra, Guevara, Medina, Tapiero, Huertas, Riaño-Moreno, Mejía, Gonzalez-Clavijo, Tapiero-García, Cuéllar-Cuéllar, Fierro-Maya and Sanabria-Salas.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JAMA. 2002 Mar 20;287(11):1427-34
pubmed: 11903030
Clin Genet. 2016 Jan;89(1):128-32
pubmed: 25827221
Clin Endocrinol (Oxf). 2006 Dec;65(6):699-705
pubmed: 17121518
Endocr Relat Cancer. 2011 Dec 01;18(6):R253-76
pubmed: 22041710
Nat Rev Cancer. 2014 Feb;14(2):108-19
pubmed: 24442145
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Med Genet. 2022 Aug;59(8):785-792
pubmed: 34452955
World J Surg. 2012 Jun;36(6):1389-94
pubmed: 22270996
J Med Genet. 2008 Apr;45(4):233-8
pubmed: 18057081
Endocr Relat Cancer. 2017 Aug;24(8):L51-L55
pubmed: 28566531
Horm Metab Res. 2012 May;44(5):328-33
pubmed: 22328163
Oncotarget. 2019 Oct 15;10(57):5919-5931
pubmed: 31666924
Ann Surg. 2018 Jul;268(1):172-178
pubmed: 28257320
Endocr Relat Cancer. 2013 Dec 16;21(1):17-25
pubmed: 24169644
BMC Med Genet. 2010 Jun 11;11:92
pubmed: 20540712
J Clin Endocrinol Metab. 2009 May;94(5):1701-5
pubmed: 19258401
Front Mol Neurosci. 2019 Jan 25;12:6
pubmed: 30740044
Science. 2017 Jul 7;357(6346):
pubmed: 28684471
Hypertens Res. 2020 Nov;43(11):1141-1151
pubmed: 32778780
N Engl J Med. 2002 May 9;346(19):1459-66
pubmed: 12000816
Eur J Endocrinol. 2019 Sep;181(3):301-309
pubmed: 31370003
Clin Cancer Res. 2017 Jun 1;23(11):e6-e13
pubmed: 28572262
Pediatr Nephrol. 2020 Apr;35(4):581-594
pubmed: 30603807
Endocrinol Nutr. 2008 May;55(5):202-16
pubmed: 22967914
Genes Chromosomes Cancer. 2006 Mar;45(3):213-9
pubmed: 16258955
Endocr Regul. 2017 Jul 1;51(3):168-181
pubmed: 28858847
Eur J Endocrinol. 2016 May;174(5):G1-G10
pubmed: 27048283
Int J Mol Sci. 2022 Jan 05;23(1):
pubmed: 35008989
J Med Genet. 2018 Jun;55(6):384-394
pubmed: 29386252
J Nucl Med. 2019 May;60(5):623-630
pubmed: 30291194
BMC Med Genet. 2005 Nov 16;6:39
pubmed: 16288654
J Intern Med. 2019 Feb;285(2):187-204
pubmed: 30536464
Cancer Genet. 2012 Jan-Feb;205(1-2):1-11
pubmed: 22429592
Nat Rev Endocrinol. 2015 Feb;11(2):101-11
pubmed: 25385035
Hum Mutat. 2010 Jan;31(1):41-51
pubmed: 19802898
Sisli Etfal Hastan Tip Bul. 2020 Jun 03;54(2):159-168
pubmed: 32617052
Am J Hum Genet. 2001 Jul;69(1):49-54
pubmed: 11404820
Clin Transl Oncol. 2021 Oct;23(10):1995-2019
pubmed: 33959901
Hematol Oncol Clin North Am. 2016 Feb;30(1):135-50
pubmed: 26614373
J Clin Endocrinol Metab. 2004 Nov;89(11):5694-9
pubmed: 15531530
Endocr Relat Cancer. 2015 Aug;22(4):T91-103
pubmed: 26273102
Horm Metab Res. 2019 Jul;51(7):470-482
pubmed: 31307109
Sisli Etfal Hastan Tip Bul. 2020 Sep 08;54(3):271-280
pubmed: 33312023
Eur J Intern Med. 2018 May;51:68-73
pubmed: 29361475

Auteurs

María Carolina Manotas (MC)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Ana Lucía Rivera (AL)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Ana Milena Gómez (AM)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Patricia Abisambra (P)

Department of Medicine, Universidad del Norte, Barranquilla, Colombia.

Gonzalo Guevara (G)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Vilma Medina (V)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Sandra Tapiero (S)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Antonio Huertas (A)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Julián Riaño-Moreno (J)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Juan Carlos Mejía (JC)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Angélica María Gonzalez-Clavijo (AM)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Mireya Tapiero-García (M)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Andrés Arturo Cuéllar-Cuéllar (AA)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

Luis Felipe Fierro-Maya (LF)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.

María Carolina Sanabria-Salas (MC)

Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.
Subdirection of Research, Instituto Nacional de Cancerología, Bogotá, Colombia.

Classifications MeSH